Hepatitis B virus (HBV) reactivation occurs as a major complication of immunosuppressive
therapy among persons who have recovered from acute hepatitis and those who have …

Even though an approved vaccine for hepatitis B virus (HBV) is available and widely used,
over 257 million individuals worldwide are living with chronic hepatitis B (CHB) who require …

Hepatitis B virus (HBV) infection is a global health problem that causes a wide range of
pathological outcomes, including cirrhosis and hepatocellular carcinoma (HCC) …

In the present work, electrochemical aptasensor for earlier detection of Hepatitis B virus
infection was developed. First, the surface of a glassy carbon electrode was modified with …

Liver damage can progress through different stages, resulting in cirrhosis or hepatocellular
carcinoma (HCC), conditions that are often associated with viral infections. Globally, 42 …

Background The ubiquitin proteasome system (UPS) regulates the expression levels of
cellular proteins by ubiquitination of protein substrates followed by their degradation via the …

After infection of hepatitis B virus (HBV), the virus induces a variety of immune disorders in
the host, leading to immune escape and, finally, the chronicity of the disease. This study …

The hepatitis B surface antigen (HBsAg) is a multifunctional glycoprotein composed of large
(LHB), middle (MHB), and small (SHB) subunits. HBsAg isoforms have numerous biological …

Early innate viral recognition by the host is critical for the rapid response and subsequent
clearance of an infection. Innate immune cells patrol sites of infection to detect and respond …

The expression of viral antigens in chronic hepatitis B virus (HBV) infection drives
continuous liver inflammation, one of the main risk factors to develop liver cancer. HBV …